Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

January 2012 - FRMC

Effects of Norovirus VLP Vaccine
01/25/2012
Although noroviruses are a leading cause of epidemic acute gastroenteritis and sporadic cases of acute gastroenteritis, a reliable vaccine for these types of viruses has not yet been developed, nor has any specific therapy been developed to...
Although noroviruses are a leading cause of epidemic acute gastroenteritis and sporadic cases of acute gastroenteritis, a reliable vaccine for these types of viruses has not yet been developed, nor has any specific therapy been developed to...
Although noroviruses are a...
01/25/2012
First Report Managed Care
Measuring Longitudinal Change of Biomarkers in Cognitive Decline
01/25/2012
Researchers have known that using biomarkers to facilitate early detection of Alzheimer disease (AD) is crucial for developing potential treatment. Studies have shown that Aβ42 and tau protein levels in cerebrospinal fluid (CSF),...
Researchers have known that using biomarkers to facilitate early detection of Alzheimer disease (AD) is crucial for developing potential treatment. Studies have shown that Aβ42 and tau protein levels in cerebrospinal fluid (CSF),...
Researchers have known that...
01/25/2012
First Report Managed Care
Costs and Complications Associated with Tubal Ligation
01/25/2012
Madrid—A database analysis of women <50 years of age who received a tubal ligation and had continuous insurance coverage for 1 year after the procedure found that a substantial number of patients experienced complications, which were...
Madrid—A database analysis of women <50 years of age who received a tubal ligation and had continuous insurance coverage for 1 year after the procedure found that a substantial number of patients experienced complications, which were...
Madrid—A database analysis of...
01/25/2012
First Report Managed Care
Free Heart Medications Improve Post-MI Outcomes and Drug Adherence
01/25/2012
Orlando—Enhanced prescription coverage improved medication adherence and rates of first major vascular events and decreased patient spending without increasing overall health costs when eliminating medication copays for patients following...
Orlando—Enhanced prescription coverage improved medication adherence and rates of first major vascular events and decreased patient spending without increasing overall health costs when eliminating medication copays for patients following...
Orlando—Enhanced prescription...
01/25/2012
First Report Managed Care
Apixaban Not Superior to Enoxaparin for Clot Prevention in Medically Ill Patients
01/25/2012
Orlando—The ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial found that treatment with 30 days of oral apixaban is no more effective than 1 to 2 weeks of injected enoxaparin for preventing venous thromboembolism (VTE) in...
Orlando—The ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial found that treatment with 30 days of oral apixaban is no more effective than 1 to 2 weeks of injected enoxaparin for preventing venous thromboembolism (VTE) in...
Orlando—The ADOPT (Apixaban...
01/25/2012
First Report Managed Care
AMR101’s Effect on Lipoprotein Concentration and Size
01/25/2012
Orlando—A follow-up analysis of a phase 3 trial found that patients with very high triglyceride levels who took 4 g/day of AMR101 had a significant reduction in the lipoprotein concentrations of the large very-low-density lipoprotein (VLDL),...
Orlando—A follow-up analysis of a phase 3 trial found that patients with very high triglyceride levels who took 4 g/day of AMR101 had a significant reduction in the lipoprotein concentrations of the large very-low-density lipoprotein (VLDL),...
Orlando—A follow-up analysis of...
01/25/2012
First Report Managed Care

Department

News Connection
Antibacterial Drugs and MRSA in Children
01/25/2012
Although methicillin resistance is common in Staphylococcus aureus in hospitals, the presence of such resistance in the community is also increasingly reported. It is commonly referred to as community-associated methicillin-resistant...
Although methicillin resistance is common in Staphylococcus aureus in hospitals, the presence of such resistance in the community is also increasingly reported. It is commonly referred to as community-associated methicillin-resistant...
Although methicillin resistance...
01/25/2012
First Report Managed Care
News Connection
Family History Influences AD Biomarker Abnormalities
01/25/2012
A family history (FH) of Alzheimer’s disease (AD) is linked to preclinical abnormalities in disease biomarkers, independent of the risk conferred by the apolipoprotein E (APOE) susceptibility gene in cognitively normal middle- to older-aged...
A family history (FH) of Alzheimer’s disease (AD) is linked to preclinical abnormalities in disease biomarkers, independent of the risk conferred by the apolipoprotein E (APOE) susceptibility gene in cognitively normal middle- to older-aged...
A family history (FH) of...
01/25/2012
First Report Managed Care
Conference Insider
Rivaroxaban Reduces Death Rates in ACS Patients
01/25/2012
Orlando—The anticlotting drug rivaroxaban added to standard medical treatment lowered the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in acute coronary syndrome (ACS) patients, but was associated with an increase...
Orlando—The anticlotting drug rivaroxaban added to standard medical treatment lowered the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in acute coronary syndrome (ACS) patients, but was associated with an increase...
Orlando—The anticlotting drug...
01/25/2012
First Report Managed Care

News

News
First-Year Cost of Administering and Monitoring Therapies for Multiple Sclerosis
01/25/2012
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an...
01/25/2012
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
OptumRx Significantly Reduces Opioid Prescribing With Management Program
08/25/2017
OptumRx has announced initial results of its Opioid Risk Management program, which the company now plans to roll out nationwide in light of its early success.
OptumRx has announced initial results of its Opioid Risk Management program, which the company now plans to roll out nationwide in light of its early success.
OptumRx has announced initial...
08/25/2017
First Report Managed Care
Conference Insider
Managing Testosterone Levels When Dosing is Delayed for Prostate Cancer
03/19/2021
In a study presented at the NCCN annual congress, Gel-LA was more likely to suppress testosterone rates over an extended period of time than Msphere-LA.
In a study presented at the NCCN annual congress, Gel-LA was more likely to suppress testosterone rates over an extended period of time than Msphere-LA.
In a study presented at the NCCN...
03/19/2021
Oncology
State Medicaid Directors Discuss Expansion
04/17/2014
Falls Church—When President Barack Obama signed the Patient Protection and Affordable Care Act (ACA) into law in March 2010, the legislation included a provision in which the federal government would stop making payments to states if they did...
Falls Church—When President Barack Obama signed the Patient Protection and Affordable Care Act (ACA) into law in March 2010, the legislation included a provision in which the federal government would stop making payments to states if they did...
Falls Church—When President...
04/17/2014
First Report Managed Care
News
Medicaid Contract Bleeds New York
07/11/2011
07/11/2011
First Report Managed Care
News
Walmart, Largest US Private Sector Employer, Cutting Health Benefits for Employees
10/07/2014
Walmart Stores Inc, the largest private sector employer in the United States, said on it would no longer provide health benefits to some of its US part-time workers due to rising healthcare costs. This change applies to part-time employees...
Walmart Stores Inc, the largest private sector employer in the United States, said on it would no longer provide health benefits to some of its US part-time workers due to rising healthcare costs. This change applies to part-time employees...
Walmart Stores Inc, the largest...
10/07/2014
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

January 2012 Volume 9 Issue 1

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement